Abbott Laboratoriesvs.IDEXX Laboratories
ABT vs IDXX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 4.2× larger than IDEXX Laboratories by market cap; Abbott Laboratories trades at the lower P/E (31.8 vs 36.0).
Side by side
| ABT | IDXX | |
|---|---|---|
| Market cap | $172B | $41B |
| Price | $99.60 | $518.00 |
| Today | +1.1% | +0.9% |
| Return YTD | −21.4% | −24.2% |
| Return 1Y | −26.6% | −18.5% |
| Since June 26, 2026 | +5.8% | −6.1% |
| P/E | 31.8 | 36.0 |
| P/S | 3.7 | 9.0 |
| P/B | 3.4 | 25.4 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Abbott LaboratoriesABT
In vitro diagnostics, medical devices that include the Libre glucose sensors, nutrition products and generic medicines: Abbott runs all four.
Full ABT profile →IDEXX LaboratoriesIDXX
Vets are the customers. IDEXX sells the analysers that sit in the clinic, runs the reference laboratories that handle samples sent out, and writes the software the practice runs on.
Full IDXX profile →More ABT & IDXX comparisons
Other head-to-heads in the Diagnostics segment.